Suppr超能文献

肝铁与脂质代谢的相互作用及其与脂肪性肝炎的相关性。

Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis.

机构信息

Department of Physiology, Army Medical College, National University of Sciences and Technology, Rawalpindi 46000, Pakistan.

出版信息

World J Gastroenterol. 2012 Sep 14;18(34):4651-8. doi: 10.3748/wjg.v18.i34.4651.

Abstract

The liver is an important site for iron and lipid metabolism and the main site for the interactions between these two metabolic pathways. Although conflicting results have been obtained, most studies support the hypothesis that iron plays a role in hepatic lipogenesis. Iron is an integral part of some enzymes and transporters involved in lipid metabolism and, as such, may exert a direct effect on hepatic lipid load, intrahepatic metabolic pathways and hepatic lipid secretion. On the other hand, iron in its ferrous form may indirectly affect lipid metabolism through its ability to induce oxidative stress and inflammation, a hypothesis which is currently the focus of much research in the field of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH). The present review will first discuss how iron might directly interact with the metabolism of hepatic lipids and then consider a new perspective on the way in which iron may have a role in the two hit hypothesis for the progression of NAFLD via ferroportin and the iron regulatory molecule hepcidin. The review concludes that iron has important interactions with lipid metabolism in the liver that can impact on the development of NAFLD/NASH. More defined studies are required to improve our understanding of these effects.

摘要

肝脏是铁和脂质代谢的重要场所,也是这两种代谢途径相互作用的主要场所。尽管得出了相互矛盾的结果,但大多数研究支持铁在肝内脂质生成中起作用的假说。铁是参与脂质代谢的一些酶和转运蛋白的组成部分,因此可能直接影响肝内脂质负荷、肝内代谢途径和肝内脂质分泌。另一方面,亚铁形式的铁可能通过诱导氧化应激和炎症而间接地影响脂质代谢,这一假说目前是非酒精性脂肪性肝病/非酒精性脂肪性肝炎 (NAFLD/NASH) 领域研究的重点。本文首先讨论了铁如何直接与肝内脂质代谢相互作用,然后考虑了铁通过铁蛋白和铁调节分子铁调素在 NAFLD 进展的双重打击假说中发挥作用的新观点。综述认为,铁与肝脏脂质代谢有重要的相互作用,可影响 NAFLD/NASH 的发生。需要更明确的研究来加深我们对这些影响的理解。

相似文献

1
Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis.
World J Gastroenterol. 2012 Sep 14;18(34):4651-8. doi: 10.3748/wjg.v18.i34.4651.
2
Hepatic lipid metabolism and non-alcoholic fatty liver disease.
Nutr Metab Cardiovasc Dis. 2009 May;19(4):291-302. doi: 10.1016/j.numecd.2008.12.015. Epub 2009 Apr 8.
4
Importance of iron and iron metabolism in nonalcoholic fatty liver disease.
Mini Rev Med Chem. 2008 Feb;8(2):171-4. doi: 10.2174/138955708783498087.
6
Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis.
Am J Physiol Gastrointest Liver Physiol. 2011 Nov;301(5):G865-76. doi: 10.1152/ajpgi.00150.2011. Epub 2011 Aug 4.
7
Iron overload in nonalcoholic steatohepatitis.
Adv Clin Chem. 2011;55:105-32. doi: 10.1016/b978-0-12-387042-1.00006-x.
8
Iron and non-alcoholic fatty liver disease.
World J Gastroenterol. 2016 Sep 28;22(36):8112-22. doi: 10.3748/wjg.v22.i36.8112.
9
Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis.
Curr Gastroenterol Rep. 2003 Feb;5(1):18-25. doi: 10.1007/s11894-003-0005-y.
10
Alterations in lipid, carbohydrate and iron metabolism in patients with non-alcoholic steatohepatitis (NASH) and metabolic syndrome.
Eur J Intern Med. 2011 Jun;22(3):305-10. doi: 10.1016/j.ejim.2011.01.011. Epub 2011 Feb 12.

引用本文的文献

1
Antioxidant Supplementation in Childhood Obesity: A Path to Improved Metabolic Health?
Antioxidants (Basel). 2025 Apr 13;14(4):466. doi: 10.3390/antiox14040466.
3
Extracellular RNA mediates iron-induced toxicity and inflammatory signalling in hepatic cells.
Toxicol Rep. 2025 Jun;14:102002. doi: 10.1016/j.toxrep.2025.102002.
5
Iron overload is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes.
Obesity (Silver Spring). 2025 Mar;33(3):490-499. doi: 10.1002/oby.24236. Epub 2025 Feb 6.
8
Multi-layered metabolic effects of trehalose on the liver proteome in apoE-knockout mice model of liver steatosis.
Pharmacol Rep. 2024 Aug;76(4):902-909. doi: 10.1007/s43440-024-00615-3. Epub 2024 Jun 24.
10
Remnant cholesterol, iron status and diabetes mellitus: a dose-response relationship and mediation analysis.
Diabetol Metab Syndr. 2024 Mar 12;16(1):65. doi: 10.1186/s13098-024-01304-0.

本文引用的文献

2
Iron overload in nonalcoholic steatohepatitis.
Adv Clin Chem. 2011;55:105-32. doi: 10.1016/b978-0-12-387042-1.00006-x.
3
Hepatic iron loading in mice increases cholesterol biosynthesis.
Hepatology. 2010 Aug;52(2):462-71. doi: 10.1002/hep.23712.
6
Insulin resistance in nonalcoholic fatty liver disease.
Curr Pharm Des. 2010 Jun;16(17):1941-51. doi: 10.2174/138161210791208875.
7
Metabolic response to iron deficiency in Saccharomyces cerevisiae.
J Biol Chem. 2010 May 7;285(19):14823-33. doi: 10.1074/jbc.M109.091710. Epub 2010 Mar 15.
8
HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
Gastroenterology. 2010 Mar;138(3):905-12. doi: 10.1053/j.gastro.2009.11.013. Epub 2009 Nov 18.
9
Pathogenesis of non-alcoholic fatty liver disease.
QJM. 2010 Feb;103(2):71-83. doi: 10.1093/qjmed/hcp158. Epub 2009 Nov 13.
10
Mechanisms of disease progression in nonalcoholic fatty liver disease.
Semin Liver Dis. 2008 Nov;28(4):370-9. doi: 10.1055/s-0028-1091981. Epub 2008 Oct 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验